In 6 patients on continuous ambulatory peritoneal dialysis we investigated the inhibition of intraperitoneal fibrin formation by heparin. A continuous addition of 500 U of heparin per liter dialysate was used for 52 h. In plasma no heparin activity could be detected, even 52 h after in...
Connective tissue growth factor (CTGF/CCN2) is increased in peritoneal dialysis patients with high peritoneal solute transport rate Peritoneal fibrosis (PF) is an important complication of peritoneal dialysis (PD) therapy that often occurs in association with peritoneal high transport r... M Mizutani...
Pleiotropic effects of heparin and heparinoids in peritoneal dialysis. Unfractionated heparin, low-molecular-weight heparins, and sulodexide belong to the family of glycosaminoglycans. Recent studies report on properties other... Joanna,Gozdzikiewicz,Jacek,... - 《Clinical & Applied Thrombosis/hemostasi...
Finally, she was accepted for the continuous ambulatory peritoneal dialysis program. This report highlighted the importance of clinical awareness as far as previous heparin exposure is concerned for establishing an early diagnosis and delivering treatment of this life-threatening prothrombotic complication of...
Peritoneal dialysis is the therapy of choice for end-stage renal disease patients with hereditary clotting disorders. Chronic renal failure is an unusual complication of hereditary clotting disorders (HCDs), but this situation could change in the near future. The modality ... M Bajo - 《Adv Perit...
Intraperitoneal application of low-molecular-weight heparin in continuous ambulatory peritoneal dialysis in a child. A method is described for continuous, long term, ambulatory, out-patient, intravenous heparin therapy in human subjects. A portable light-weight pump originally designed for ambulatory, con...
Membrane complement regulators protect against fibrin exudation increases in a severe peritoneal inflammation model in rats. Peritonitis and the rare sequela of encapsulating peritoneal sclerosis (EPS) are serious problems in patients on peritoneal dialysis therapy. Chronic and p... Mizuno,Masashi - 《...
- 《Nephrology Dialysis Transplantation Official Publication of the European Dialysis & Transplant Association European Renal Association》 被引量: 24发表: 2013年 Platelet surface receptor activation in patients with chronic renal failure on hemodialysis, peritoneal dialysis and those with successful kidney ...
9 RegisterLog in Sign up with one click: Facebook Twitter Google Share on Facebook Medical Translations Spanish / Español Select a language: hep·a·rin·ize n.heparinizar, evitar la coagulación por medio del uso de heparina. English-Spanish Medical Dictionary © Farlex 2012 ...
For heparin, infusion was started with 10 international units (IU)/kg/hr pre-filter. The heparin dose was subsequently adjusted toward a target postfilter activated clotting time (ACT) of 180–220 s. Dialysis and replacement solutions were the Dialisan (DVVHD BG2D, Baxter) and Prism0calB...